Responses of T cells to ligands for the T-cell receptor

By Janeway Jr C.A.   Bottomly K.  

Seminars in Immunology, Vol. 8, Iss. 2, 1996-02 ,pp. : 109-115

Academic Press

Access to resources Recommend Favorite

Her-2/neu altered peptide ligand–induced CTL responses: implications for peptides with increased HLA affinity and T-cell-receptor interaction

By Dionne Sara   Myers Cheryl   Smith Margaret   Lake Douglas  

Cancer Immunology, Immunotherapy, Vol. 53, Iss. 4, 2004-04 ,pp. : 307-314

Springer Publishing Company

Access to resources Recommend Favorite

Monitoring tumor antigen specific T-cell responses in cancer patients and phase I clinical trials of peptide-based vaccination

By Romero Pedro   Cerottini Jean-Charles   Speiser Daniel  

Cancer Immunology, Immunotherapy, Vol. 53, Iss. 3, 2004-03 ,pp. : 249-255

Springer Publishing Company

Access to resources Recommend Favorite

Introduction: T-cell recognition of variant ligands

By Allen P.M.  

Seminars in Immunology, Vol. 8, Iss. 2, 1996-02 ,pp. : 61-61

Academic Press

Access to resources Recommend Favorite

Progress in treatment of peripheral T-cell lymphoma with hematopoietic stem cell transplantation

By Zhou Lilan   He Mingsheng  

The Chinese-German Journal of Clinical Oncology, Vol. 10, Iss. 5, 2011-05 ,pp. : 293-296

Springer Publishing Company

Access to resources Recommend Favorite